These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37727903)
1. Medicinal-Chemistry-Driven Approach to 2-Substituted Benzoxazole-Estradiol Chimeras: Synthesis, Anticancer Activity, and Early ADME Profile. Kovács F; Huliák I; Árva H; Kiricsi M; Erdős D; Kocsis M; Takács G; Balogh GT; Frank É ChemMedChem; 2023 Nov; 18(22):e202300352. PubMed ID: 37727903 [TBL] [Abstract][Full Text] [Related]
2. Substitutional Diversity-Oriented Synthesis and In Vitro Anticancer Activity of Framework-Integrated Estradiol-Benzisoxazole Chimeras. Kovács F; Adamecz DI; Nagy FI; Papp B; Kiricsi M; Frank É Molecules; 2022 Nov; 27(21):. PubMed ID: 36364293 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and Kuzu B; Hepokur C; Turkmenoglu B; Burmaoglu S; Algul O Future Med Chem; 2022 Jul; 14(14):1027-1048. PubMed ID: 35703122 [TBL] [Abstract][Full Text] [Related]
5. New steroidal oxazolines, benzoxazoles and benzimidazoles related to abiraterone and galeterone. Latysheva AS; Zolottsev VA; Veselovsky AV; Scherbakov KA; Morozevich GE; Pokrovsky VS; Novikov RA; Timofeev VP; Tkachev YV; Misharin AY Steroids; 2020 Jan; 153():108534. PubMed ID: 31678134 [TBL] [Abstract][Full Text] [Related]
6. Efficient access to domain-integrated estradiol-flavone hybrids via the corresponding chalcones and their in vitro anticancer potential. Molnár B; Gopisetty MK; Nagy FI; Adamecz DI; Kása Z; Kiricsi M; Frank É Steroids; 2022 Nov; 187():109099. PubMed ID: 35970223 [TBL] [Abstract][Full Text] [Related]
7. In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors. Desai S; Desai V; Shingade S Bioorg Chem; 2020 Jan; 94():103382. PubMed ID: 31662214 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and apoptotic effects of novel benzoxazole compounds. Kaya B; Yurttaş L; Akalın-Çiftçi G; Aksoy MO Z Naturforsch C J Biosci; 2023 Nov; 78(11-12):433-440. PubMed ID: 37903727 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities. Osmaniye D; Korkut Çelikateş B; Sağlık BN; Levent S; Acar Çevik U; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA Eur J Med Chem; 2021 Jan; 210():112979. PubMed ID: 33183865 [TBL] [Abstract][Full Text] [Related]
16. Current Scenario of 1,3-oxazole Derivatives for Anticancer Activity. Yan X; Wen J; Zhou L; Fan L; Wang X; Xu Z Curr Top Med Chem; 2020; 20(21):1916-1937. PubMed ID: 32579505 [TBL] [Abstract][Full Text] [Related]
17. Benzoxazole-appended piperidine derivatives as novel anticancer candidates against breast cancer. AboulWafa OM; Daabees HMG; El-Said AH Bioorg Chem; 2023 May; 134():106437. PubMed ID: 36842320 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer. El-Ghobashy NM; El-Sayed SM; Shehata IA; El-Ashmawy MB Sci Rep; 2022 Sep; 12(1):16246. PubMed ID: 36171229 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1. Kumar D; Jacob MR; Reynolds MB; Kerwin SM Bioorg Med Chem; 2002 Dec; 10(12):3997-4004. PubMed ID: 12413851 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma. Dadashpour S; Küçükkılınç TT; Ercan A; Hosseinimehr SJ; Naderi N; Irannejad H Anticancer Agents Med Chem; 2019; 19(17):2120-2129. PubMed ID: 31393257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]